Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT01313442
- Status
- Recruiting
Conditions
- Cancer of Gastrointestinal Tract
- Gastrointestinal Cancer
- Non-GI Cancers
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating how active the immune system is in trying to fight the cancer by studying blood and tumor tissue donated from individuals who have been diagnosed with gastrointestinal cancers. Objectives: \- To collect blood and tumor samples from individuals who have been diagnosed with gastrointestinal cancers in order to study the immune system s response to the cancer. Eligibility: \- Individuals at least 18 years of age who have been diagnosed with throat, stomach, gallbladder, liver, pancreatic, or colon cancer, and are scheduled to be treated at the National Institutes of Health. Design: * The study will require at least one but no more than four visits to the National Institutes of Health Clinical Center. * Participants will be screened with a physical examination and medical history, and will provide a baseline blood sample for study. * Participants will provide additional blood samples 2 and 4 months after the baseline sample, as well as a final sample at the completion of the treatment protocol. * Participants will provide tumor tissue samples only if they undergo a surgical procedure related to the treatment for their gastrointestinal cancer. * No treatment will be provided as part of this protocol.
Key Dates
- Start date
- Mar 2, 2011
- Status verified
- Apr 2026
Study Design
- Enrollment
- 550 participants (estimated)
Arms
- Arm: 1/ Cohort 1Individuals with a diagnosis of cancer
Primary Outcome Measure
Collected samples [ Time Frame: 10 years ]
Central Contacts
- Stephanie N Hicks(240) 760-6159
- Tim F Greten, M.D.(240) 760-6114
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 |
Find similar trials in Bethesda, MD
Related Studies
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsPHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesPHASE1 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland